Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04321343. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 36-week, Randomized, Double-blind, Placebo-controlled, Parallel Group Trial to Assess the Efficacy and Safety of PXL065 Versus Placebo in Noncirrhotic Biopsy-proven NonAlcoholic SteatoHepatitis (NASH) Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the effect of 3 doses of PXL065 versus placebo on liver fat content in NASH patients after 36 weeks of treatment
Study identification
- NCT ID
- NCT04321343
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 117 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 1, 2020 (Actual)
- Primary completion
- Jun 8, 2022 (Actual)
- Completion
- Jun 20, 2022 (Actual)
- Last update posted
- Aug 29, 2023
2020 – 2022
United States locations
- U.S. sites
- 29
- U.S. states
- 11
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study site 11 | Chandler | Arizona | 85224 | — |
| Study site 12 | Glendale | Arizona | 85306 | — |
| Study site 13 | Tucson | Arizona | 85712 | — |
| Study site 21 | Tucson | Arizona | 85712 | — |
| Study site 17 | Chula Vista | California | 91910 | — |
| Study site 16 | Fresno | California | 93720 | — |
| Study site 04 | Huntington Park | California | 90255 | — |
| Study site 05 | Los Angeles | California | 90057 | — |
| Study site 22 | Orange | California | 92866 | — |
| Study site 06 | Panorama City | California | 90402 | — |
| Study site 07 | Santa Ana | California | 92704 | — |
| Study site 15 | Boca Raton | Florida | 33434 | — |
| Study site 31 | Fort Myers | Florida | 33912 | — |
| Study site 08 | Port Orange | Florida | 32127 | — |
| Study site 01 | Sarasota | Florida | 34240 | — |
| Study site 28 | West Des Moines | Iowa | 50265 | — |
| Study site 18 | Kansas City | Kansas | 61431 | — |
| Study site 24 | Flowood | Mississippi | 39232 | — |
| Study site 10 | Jackson | Mississippi | 39216 | — |
| Study site 27 | East Syracuse | New York | 13057 | — |
| Study site 14 | Fayetteville | North Carolina | 28304 | — |
| Study site 29 | Summerville | South Carolina | 29485 | — |
| Study site 25 | Chattanooga | Tennessee | 37411 | — |
| Study site 30 | Clarksville | Tennessee | 37040 | — |
| Study Site 02 | Germantown | Tennessee | 38138 | — |
| Study site 19 | Austin | Texas | 78746 | — |
| Study site 09 | Edinburg | Texas | 78539 | — |
| Study site 23 | Edinburg | Texas | 78539 | — |
| Pinnacle Clinical Research (Study site 20) | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04321343, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2023 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.